Asthma Digital Study

Elevance Health901 enrolled

Overview

The Asthma Digital Study is a virtual, two-arm, randomized, controlled trial that will investigate the impact of digital tools on asthma symptom control, exacerbation frequency, healthcare utilization, and medical expenditures. Adults with asthma will be randomized to the passive or active arm in a 1:1 ratio. All participants will be sent two devices, at no cost-an Apple Watch and a Beddit Sleep Monitor. These are publicly available, commercial devices that have not been modified for this study. The study will be administered largely through a customized version of CareEvolution's MyDataHelps app (the "Study App"). Access to the Study App will be provided to all participants. It will be used to administer informed consent and electronic patient reported outcome (ePRO) measures, and for other study purposes. Only active arm participants will have access to Study App features designed to support asthma self-management. These features include "smart nudges" based on device data, symptom and trigger tracking, evidence-based education, summaries of health metrics gathered from the Apple Watch and Beddit Sleep Monitor, in-app medication refill resources, as well as other resources. The study duration is 2 years. Participants can keep using the Study App and devices after Year 1, though this is not required. Primary analyses will utilize Year 1 data only. During Year 2, data collection will continue where available, though fewer data will be collected because use of digital tools is not required during Year 2, and health coverage changes may cause loss of access to claims data.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

OTHER

Masking

NONE

Enrollment

901

Conditions

Asthma

Interventions

Digital Tools for Asthma Self-ManagementOTHER

Please see description of active study arm.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 64 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Health insurance coverage through an Anthem, Inc. affiliate. * 18-64 years of age * Resident of the United States for the duration of the study * Comfortable reading and writing in English * Owns an iPhone 6s or later * Has been diagnosed with asthma by a provider * 1+ emergency department visit in the preceding 24 months with an associated asthma diagnosis, or a combination of factors that might be associated with uncontrolled asthma. Factors include: * History of asthma medication prescriptions * History of asthma-associated primary care visits * Diagnosis of chronic sinusitis, pharyngitis, influenza, allergic rhinitis, hypertension, diabetes, and/or obesity * History of smoking * Age and zip code Exclusion Criteria: * Unable to sleep in a bed with a Beddit sleep monitor at least 5 nights per week on average (e.g., shift workers who experience limited or erratic night-time sleep schedule, frequent travelers unable to stably sleep on the sensor at the requisite rate) * Currently enrolled in any other asthma or pulmonary studies * Currently on any immunologic for asthma * Participated in a prior pilot study investigating the same digital tools * Member of an Anthem plan with annual incentives limits of $100 or less * Resident of Puerto Rico * Pregnancy * Diagnosis of any of the following: * Chronic Obstructive Pulmonary Disease/Emphysema * Cystic Fibrosis * Any malignancy other than a non-melanoma skin cancer * Any dementia diagnosis * Neurodegenerative diseases (e.g., Parkinson's) * Schizophrenia * Heart failure * On dialysis * Women who are postpartum, with delivery in the past 8 weeks

Locations (1)

Jordan Silberman

Palo Alto, California, United States

Outcomes

Primary Outcomes

Change in asthma-associated expenditures due to emergency department and hospital utilization

Sum of all allowed costs for emergency and hospital care, where asthma is specified as a diagnosis. Costs from the 12 months preceding baseline will be compared to costs from 12 months after baseline. Mean change in costs will be compared across arms.

Time frame: 12 months before and after baseline

Change from baseline in Asthma Control Test (ACT), a validated patient-reported outcome (PRO) measure of asthma symptom control

ACT change among all participants with baseline ACT score suggesting that asthma may be uncontrolled (ACT score of 19 or lower). Mean ACT change will be compared across arms.

Time frame: Baseline and 12-month time points

Secondary Outcomes

Change from baseline in Asthma Control Test (ACT), a validated patient-reported outcome (PRO) measure of asthma symptom control

Change from baseline among active arm participants with baseline ACT score suggesting that asthma may be uncontrolled (ACT score of 19 or lower).

Time frame: Active arm only: Baseline and months 1, 2, 3, 4, 5, 6, 8, 10, 12

Adherence to Refills and Medications Scale, 7-item version (ARMS-7)

Validated PRO measure of medication adherence

Time frame: Active arm only: 2 weeks and months 2, 4, 6, 8, 10, 12

Readiness ruler, asthma self-management

PRO measuring confidence in, and perceived importance of, asthma self-management

Time frame: Active arm only: 2 weeks and months 2, 4, 6, 8, 10, 12

Work Productivity and Activity Impairment Questionnaire 2.0, asthma version

Validated PRO measure of asthma-associated work productivity impairment

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.